29.02.2012 • News

Haltermann Reports Postive First 6 Months

Six months after Haltermann, previously a subsidiary of Dow, became an independent company, Haltermann's CEO, Dr. Uwe Nickel has expressed satisfaction with how business is developing. Dr Nickel is optimistic about the future. Since the company was spun-off in July 2011, Haltermann, which specializes in high-purity refinery chemicals, increased its revenue by 20% over the previous year. In a press release, the company said it has been able to pass on the high price increase of raw materials. Nickel is cautious about 2012 expectations.

"We will only have clarity about the market development after the first three to five months of 2012," he said.

 

 

 

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read